AI in Medical Diagnostics Market Report 2026

The AI in medical diagnostics market size has grown exponentially in recent years. It will grow from $2.66 billion in 2025 to $3.79 billion in 2026 at a compound annual growth rate (CAGR) of 42.7%. The growth in the historic period can be attributed to growth in diagnostic imaging volumes, shortage of skilled radiologists, need for early disease detection, expansion of digital diagnostics, increasing healthcare data availability.

The AI in medical diagnostics market size is expected to see exponential growth in the next few years. It will grow to $14.03 billion in 2030 at a compound annual growth rate (CAGR) of 38.7%. The growth in the forecast period can be attributed to rising adoption of AI imaging tools, increasing demand for faster diagnostics, growth of precision medicine, integration of AI with clinical systems, expansion of cloud-based diagnostics. Major trends in the forecast period include ai-based disease detection, computer-aided diagnostic systems, predictive diagnostic analytics, automation of diagnostic workflows, data-driven clinical insights.

The rising investment in healthcare is anticipated to drive the growth of the AI in medical diagnostics market in the coming years. Health expenditure refers to the share of total income allocated by both public and private sectors toward healthcare services. It generates employment for healthcare professionals, increases earnings for healthcare workers, enhances municipal tax revenues, and stimulates demand for related goods and services that support the adoption of AI technologies in healthcare. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health expenditure is expected to reach $344 billion in 2023, registering a moderate growth of 2.8% compared to the previous year. Thus, the growing investment in healthcare is contributing to the expansion of the AI in medical diagnostics market.

Major companies operating in the AI in medical diagnostics market are concentrating on developing advanced solutions such as digital pod-based primary care platforms to improve patient experience and operational efficiency. Digital pod-based primary care platforms are modular clinics that combine AI-driven consultations, diagnostics, testing, and medication dispensing into a unified workflow to deliver rapid care. For instance, in November 2024, Forte Healthcare, a UAE-based healthcare company, introduced MediBAY, an AI-powered clinic model that allows patients to complete their entire healthcare journey in under 30 minutes. Key features of the launched product include AI-based consultations, testing, diagnostics, and medication dispensing through digital pods designed for immediate care needs; multilingual live tele-consultations with physicians and trained nurses to support efficient patient flow; blockchain-enabled safety and compliance along with the integration of patient records, diagnostics, and prescriptions into a single system; a design that decreases the burden on general practitioners and hospital facilities by improving access to quality primary care; and advanced AI, robotics, and automation developed in collaboration with academic and industry experts to establish new digital healthcare standards.

In October 2024, GE HealthCare Technologies Inc., a medical technology company based in the U.S., acquired Intelligent Ultrasound Group PLC for around $53 million. This acquisition allows GE HealthCare to incorporate Intelligent Ultrasound's AI-driven tools into its ultrasound offerings, aiming to improve workflow efficiency, minimize repetitive tasks, and simplify ultrasound examinations for clinicians. Intelligent Ultrasound Group PLC, a diagnostics company located in the UK, focuses on AI-driven ultrasound software and training tools for medical diagnostics.

Major companies operating in the AI in medical diagnostics market are International Business Machines Corporation; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Digital Diagnostics Inc.; Heartflow Inc.; Aidoc Medical Ltd.; Koninklijke Philips N.V.; Nanox Imaging Ltd.; Enlitic Inc.; Aidence B.V.; Butterfly Network Inc.; Day Zero Diagnostics Inc.; Arterys Inc.; PathAI Inc.; Zebra Medical Vision Inc.; Caption Health Inc.; Proscia Inc.; AliveCor Corporation; ResApp Health Limited; Volpara Health Technologies Limited.

North America was the largest region in the AI in medical diagnostics market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global AI in medical diagnostics market report during the forecast period. The regions covered in the AI in medical diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the AI in medical diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the AI in medical diagnostics market by increasing costs of imported imaging equipment, servers, and high-performance computing hardware. These impacts are most visible in hospitals and diagnostic imaging centers using advanced ai-powered systems. Regions such as asia pacific and europe face supply chain pressures due to reliance on imported diagnostic components. At the same time, tariffs have accelerated the shift toward software-based diagnostic solutions. This has supported wider adoption of cloud-native and scalable AI diagnostic platforms.

The AI in medical diagnostics market research report is one of a series of new reports that provides AI in medical diagnostics market statistics, including AI in medical diagnostics industry global market size, regional shares, competitors with a AI in medical diagnostics market share, detailed AI in medical diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the AI in medical diagnostics industry. This AI in medical diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

AI in medical diagnostics involves the application of artificial intelligence in the field of treatment and medical diagnostics. It is employed to analyze medical imaging data, including X-rays, MRIs, ultrasounds, CT scans, and DXAs, with the aim of assisting doctors in more precise and rapid disease discovery and diagnosis.

The primary components of AI in medical diagnostics encompass software and services. The software utilized in medical diagnostics can detect various indicators, such as the abnormal proliferation of molecules in cells that may signify a disease, through image processing. Technologies involved in this process include natural language processing, computer vision, machine learning, context-aware computing, and others. These technologies find applications in specialized diagnostic cases, such as brain and neurological, oncology, cardiac and vascular, chest and lung, obstetrics and gynecology, among others. They are applied through computer-aided detection, computer-aided diagnosis, quantitative analysis tools, and clinical decision support systems, and are utilized by hospitals, diagnostic imaging centers, diagnostic laboratories, and other healthcare entities.

The AI in medical diagnostics market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), ultrasound, and computed tomography scans, robotic process automation, machine learning, natural language processing, and rule-based expert systems. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in the medical diagnostics market also includes sales of dental devices, diabetes care devices, nephrology and urology devices, neurology devices, and physical robots which are used in providing AI in medical diagnostics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.